Stock Events

Stock Events

Viridian Therapeutics (VRDN) Q2 2024 Earnings

8MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-1.35

-1.16

-0.98

-0.79

Details

Expected EPS

-1.089062

Actual EPS

-0.79

Surprise EPS

0.3

Surprise Percent

+27.46%

Description

Viridian Therapeutics (VRDN) has reported earnings of -0.79 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.